Showing 1511-1520 of 19295 results for "".
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
https://reachmd.com/programs/neurofrontiers/examining-inebilizumab-in-generalized-myasthenia-gravis-insights-from-mint/32859/Even though the available therapeutic options for generalized myasthenia gravis (gMG) have improved outcomes, challenges like incomplete responses, treatment fatigue, and side-effect burdens remain. That's why the MINT trial, published in The New England Journal of Medicine in June 2025, explored thImproving Lipid Management Through Equity-Focused Clinical Strategies
https://reachmd.com/programs/heart-matters/improving-lipid-management-through-equity-focused-clinical-strategies/37598/Despite advances in lipid-lowering therapies, disparities in hyperlipidemia diagnosis and treatment persist. Dr. Keith Ferdinand examines how social drivers of health impact access, adherence, and outcomes and explains how clinicians can help address gaps in care for underserved populations. Dr. FerOverview of the Latest Guidance in IgA Nephropathy Management
https://reachmd.com/programs/kdigo-conversations-nephrology/overview-of-the-latest-guidance-in-iga-nephropathy-management/37115/On this first episode of the KDIGO IgA Nephropathy (IgAN) podcast series, join host Dr. Dana Rizk and special guest Dr. Brad Rovin for a discussion on the latest guidance for managing IgAN. As an expert in glomerular diseases and co-chair of the KDIGO Glomerular Disease Guideline Working Group, Dr.Diagnosing and Treating Immune Checkpoint Inhibitor Colitis Effectively
https://reachmd.com/programs/gi-insights/diagnosing-and-treating-immune-checkpoint-inhibitor-colitis-effectively/32873/Immune checkpoint inhibitor (ICI) colitis comes with unique diagnostic and treatment challenges, which means that recognizing and managing it effectively is key to the best outcomes. Joining Dr. Peter Buch to share her insights on caring for patients with this complex condition is Dr. Yinghong Wang.Boosting Colorectal Cancer Screening in Rural Clinics: Insights from SMARTER CRC
https://reachmd.com/programs/clinicians-roundtable/boosting-colorectal-cancer-screening-in-rural-clinics-insights-from-smarter-crc/36409/The SMARTER CRC trial evaluated mailed fecal immunochemical (FIT) outreach and patient navigation strategies across rural clinics, analyzing how implementation factors like clinic-sent letters, consistent FIT usage, and active participation in health plan meetings impacted screening outcomes. Two auImproving Metastatic Breast Cancer Care Through Integrated Palliative Support
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/improving-metastatic-breast-cancer-care-through-integrated-palliative-support/36436/A 2025 study conducted at Champalimaud Clinical Center’s Breast Unit in Portugal explored the impacts of a fully embedded palliative care model for patients with metastatic breast cancer. In this AudioAbstract, Mr. Ryan Quigley dives into the findings on how proactive, integrated support may enhEvaluating Guselkumab for Pediatric Psoriasis: New Phase III Trial Data
https://reachmd.com/programs/dermconsult/evaluating-guselkumab-for-pediatric-psoriasis-new-phase-iii-trial-data/32450/The phase III PROTOSTAR study published in the Journal of the American Academy of Dermatology in March 2025 highlights new findings on the efficacy and safety of guselkumab for pediatric psoriasis. Join Dr. Amy Paller as she reviews the data and its implications for the future of pediatric psoriasisIdentifying C3G: Key Diagnostic Considerations and Challenges
https://reachmd.com/programs/frontlines-c3g/identifying-c3g-key-diagnostic-considerations-and-challenges/35487/Complement 3 glomerulopathy (C3G) presents complex diagnostic hurdles due to its rarity, clinical heterogeneity, and lack of definitive biomarkers. Tune in to hear Dr. Gates Colbert and Dr. Anuja Java discuss the need for improved biomarker development, our evolving understanding of complement dysreUnpacking Post-COVID Cognitive Changes: The Potential Role of Immune Exhaustion
https://reachmd.com/programs/clinicians-roundtable/unpacking-post-covid-cognitive-changes-the-potential-role-of-immune-exhaustion/35466/A recent prospective study evaluated long-term cognitive outcomes in post-COVID patients using advanced imaging, biomarker analysis, and specialist assessments. It revealed a pattern suggestive of immune exhaustion, including elevated markers tied to wound healing and blood-brain barrier integrity aImproving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
https://reachmd.com/programs/neurofrontiers/improving-diagnostic-accuracy-in-ms-criteria-challenges-and-innovations/32782/Accurately diagnosing multiple sclerosis (MS) involves understanding the diagnostic criteria, recognizing red flags to avoid misdiagnosis, and keeping up with new tools. Dr. Andrew Solomon, Professor and Interim Chair of the Department of Neurological Sciences and Chief of the Multiple Sclerosis Div